PL333056A1 - Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug - Google Patents

Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Info

Publication number
PL333056A1
PL333056A1 PL97333056A PL33305697A PL333056A1 PL 333056 A1 PL333056 A1 PL 333056A1 PL 97333056 A PL97333056 A PL 97333056A PL 33305697 A PL33305697 A PL 33305697A PL 333056 A1 PL333056 A1 PL 333056A1
Authority
PL
Poland
Prior art keywords
loratadin
hyperaemia
composition intended
treat asthma
reducing drug
Prior art date
Application number
PL97333056A
Other languages
English (en)
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL333056A1 publication Critical patent/PL333056A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL97333056A 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug PL333056A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
PL333056A1 true PL333056A1 (en) 1999-11-08

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333056A PL333056A1 (en) 1996-10-31 1997-10-29 Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug

Country Status (21)

Country Link
EP (1) EP0941091A1 (sk)
JP (1) JP2000505104A (sk)
KR (1) KR20000052922A (sk)
CN (1) CN1235545A (sk)
AR (1) AR008908A1 (sk)
AU (1) AU731756B2 (sk)
BR (1) BR9712705A (sk)
CA (1) CA2268546A1 (sk)
CO (1) CO4910128A1 (sk)
CZ (1) CZ150999A3 (sk)
HU (1) HUP9904075A3 (sk)
ID (1) ID23431A (sk)
IL (1) IL129662A0 (sk)
NO (1) NO992062L (sk)
NZ (1) NZ335078A (sk)
PE (1) PE11399A1 (sk)
PL (1) PL333056A1 (sk)
SK (1) SK54599A3 (sk)
TR (1) TR199901003T2 (sk)
WO (1) WO1998018470A1 (sk)
ZA (1) ZA979731B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021556A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
PE20001070A1 (es) * 1998-09-10 2000-10-19 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2697100A (en) * 1999-02-23 2000-09-14 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
AU3924500A (en) * 1999-03-29 2000-10-16 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
WO2001045668A2 (en) * 1999-12-20 2001-06-28 Schering Corporation Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
WO2001078782A1 (en) * 2000-04-14 2001-10-25 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
PE20020055A1 (es) * 2000-05-25 2002-02-12 Schering Corp Formulaciones estables liquidas y solidas que comprenden una antihistamina no sedante y un descongestionante nasal
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
AU2005333081B2 (en) 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2034970B1 (en) * 2006-06-01 2012-08-01 MSD Consumer Care, Inc. Sustained release pharmaceutical formulation comprising phenylephrine
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
AR008908A1 (es) 2000-02-23
NZ335078A (en) 2000-10-27
CA2268546A1 (en) 1998-05-07
NO992062D0 (no) 1999-04-29
HUP9904075A2 (hu) 2000-05-28
CZ150999A3 (cs) 1999-10-13
IL129662A0 (en) 2000-02-29
NO992062L (no) 1999-04-29
CN1235545A (zh) 1999-11-17
TR199901003T2 (xx) 1999-07-21
ID23431A (id) 2000-04-20
SK54599A3 (en) 2000-08-14
PE11399A1 (es) 1999-02-09
ZA979731B (en) 1998-04-29
JP2000505104A (ja) 2000-04-25
AU731756B2 (en) 2001-04-05
EP0941091A1 (en) 1999-09-15
HUP9904075A3 (en) 2002-02-28
KR20000052922A (ko) 2000-08-25
AU4995397A (en) 1998-05-22
CO4910128A1 (es) 2000-04-24

Similar Documents

Publication Publication Date Title
CZ161599A3 (cs) N-substituované 2-kyanopyrrolidiny, způsob jejich přípravy a jejich použití jako léčiv
PL333056A1 (en) Composition intended to treat asthma, containing loratadin and a hyperaemia reducing drug
IL115854A0 (en) Process for purifying and isolating 2'-deoxy-2',2'-difluoronucleosides
ZA952356B (en) Skin treatment composition
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
EP0803255A4 (en) DRUG
GB9406573D0 (en) Medicaments
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
GB9420784D0 (en) Medicaments
GB9405021D0 (en) Skin treatment composition
HU9500910D0 (en) Pyrazoline-derivatives and their use as plant desease-controlling agent
PL338123A1 (en) 6-pyrrolydin-2-ylpyridines, their production and application in therapy
AU3982695A (en) Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
GB9418530D0 (en) Medicaments
ZA952120B (en) Skin treatment composition
GB9411052D0 (en) Medicaments
GB9421133D0 (en) Medicaments
GB2291807B (en) Improvements in or relating to breathing devices
GB9416365D0 (en) Medicaments
GB9727276D0 (en) Improvements in medicaments for asthma treatment
GB9825972D0 (en) Improvements in medicaments for asthma treatment
EP0790829A4 (en) DRUG
SI0991650T1 (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
GB9418269D0 (en) Improvements to inhalation devices
GB9707589D0 (en) Improvements in and relating to treatment